SIGA Technologies Inc

$7.06 0.00% ($0.00)

Get ready to invest

About SIGA Technologies Inc

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on health security market. The Company’s lead product TPOXX is approved by the Unites States Food and Drug Administration (FDA) as a drug with an indication for treatment of smallpox. TPOXX is an oral formulation, which is also known as tecovirimat and ST-246. The Company is developing the intravenous (IV) formulation for patients who are unable to swallow oral capsules. It is also focused on developing post-exposure prophylaxis (PEP), liquid suspension pediatric formulation and ST-357. PEP regimens are designed to prevent infection in individuals who have known or exposure to an infectious agent but are not symptomatic. The Company is developing a second mechanism of action smallpox small molecule antiviral drug that has shown efficacy in animal models of the disease.

Popular Stocks	Price	Change
Kadmon Holdings Inc KDMN	$8.6 0.21%	0.21%
Ford F	$16.04 0.3%	0.3%
DiDi DIDI	$8.62 4.71%	4.71%
Fuelcell Energy Inc FCEL	$8.13 0.96%	0.96%
Vale VALE	$13.85 0.91%	0.91%
ContextLogic WISH	$6.09 1.66%	1.66%
Apple AAPL	$149.26 0.36%	0.36%
Tesla TSLA	$865.8 2.94%	2.94%
Tilray TLRY	$11.59 0.93%	0.93%